Paroxetine Tablet, Film Coated
Product Images NDC 55289-053

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 55289-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

55289053 Labels (55289053)

55289053 Labels (55289053)
This medication comes in a bottle labeled with the product code NDC 55289-053-90 and manufactured by PD-Rx Pharmaceuticals. The medication is PARoxetine 40mg which comes with 90 tablets, and each tablet contains PAROXETINE HYDROCHLORIDE. The medication is blue and manufactured by Incorporated® based in Oklahoma City. The lot code for this specific medication is G20A23 with an expiration date of 03/2022. It is important to avoid consuming alcohol or alcoholic beverages when taking this medication. The package insert should be consulted for dosage and storage instructions. The medication should be kept out of reach of children. In case of side effects or medical advice, contact your doctor.*
FDA Label Image

Image 01

FDA Label Image

Image 06

Image 06
This text provides information on five drugs - Pimozide, Desipramine, Propranolol, Digoxin, and Phenytoin - and their interactions. The text includes dosage information for each drug and provides data on the maximum concentration (Cmax) and the area under the concentration-time curve (AUC) for each drug. Additionally, the data includes fold change and confidence intervals (CI). However, without further context, it is unclear what the significance of this data is or how it should be interpreted.*
FDA Label Image

Image 07

Image 07
This appears to be a table displaying the interacting drugs Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam, along with their respective dosages. The table also includes a column titled "Fold change and 90% CI" with one cell displaying "1" indicating the reference value. The given information is insufficient to provide a more detailed description or context.*
FDA Label Image

Image 08

Image 08
Not available. The given text seems to be a table with information about population descriptions, PK fold change, and 90% CI for various factors such as renal impairment, hepatic impairment, age, and gender. However, the table seems to be incomplete and the has not been able to accurately capture the information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.